Relationship between human tumour angiogenic profile and combretastatin-induced vascular shutdown: An exploratory study

British Journal of Cancer

Volumn 99, Issue 2, 2008, Pages 321-326

  Gaya, A ^a   Daley, F ^b   Taylor, N J ^c   Tozer, G ^b   Qureshi, U ^d   Padhani, A ^c   Pedley, R B ^d   Begent, R ^d   Wellsted, D ^e   Stirling, J J ^c   Rustin, G ^f  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b Gray Cancer Institute   (United Kingdom)

^c Paul Strickland Scanner Centre   (United Kingdom)

^d ROYAL FREE HOSPITAL   (United Kingdom)

^e UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^f MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Angiogenesis; Combretastatin; Dynamic MRI; Immunohistochemistry; Microvessel density; Vascular maturity

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOPOIETIN 1; ANGIOPOIETIN 2; BETA3 INTEGRIN; CD61 ANTIGEN; COMBRETASTATIN A4 PHOSPHATE; ENDOGLIN; GLUCOSE TRANSPORTER 1; KI 67 ANTIGEN; PLATELET DERIVED GROWTH FACTOR B; VASCULOTROPIN; ACTIN; ANGIOGENIC PROTEIN; ANTINEOPLASTIC AGENT; CELL SURFACE RECEPTOR; COMBRETASTATIN A 4; COMBRETASTATIN A-4; ENG PROTEIN, HUMAN; GADOLINIUM PENTETATE; ITGB3 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; STILBENE DERIVATIVE;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; DISEASE MARKER; EXPLORATORY RESEARCH; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TISSUE SECTION; TUMOR BLOOD FLOW; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM; DRUG EFFECT; MAGNETIC RESONANCE ANGIOGRAPHY; METABOLISM; METHODOLOGY; MIDDLE AGED; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; VASCULARIZATION;

ACTINS; ADULT; AGED; ANGIOGENIC PROTEINS; ANTIGENS, CD; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ENDOTHELIUM, VASCULAR; FEMALE; GADOLINIUM DTPA; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN BETA3; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, CELL SURFACE; STILBENES;

EID: 48249103089     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604426     Document Type: Article

References (43)

1. Ahmad SA, Liu W, Jung YD, Fan F, Reinmuth N, Bucana CD, Ellis LM (2001) Differential expression of angiopoietin-1 and angiopoietin-2 in colon carcinoma. A possible mechanism for the initiation of angiogenesis. Cancer 92: 1138-1143
2. Bach F, Uddin FJ, Burke D (2007) Angiopoietins in malignancy. Eur J Surg Oncol 33: 7-15
3. Barnhill RL, Xiao M, Graves D, Antoniades HN (1996) Expression of platelet-derived growth factor (PDGF)-A, PDGF-B and the PDGF-alpha receptor, but not the PDGF-beta receptor, in human malignant melanoma in vivo. Br J Dermatol 135: 898-904
4. Barresi V, Cerasoli S, Vitarelli E, Tuccari G (2007) Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas. Acta Neuropathol (Berl) 114: 147-156
5. Bland J, Altman D (1996) Measurement error proportional to the mean. BMJ 313: 744
6. Buckley DL, Drew PJ, Mussurakis S, Monson JR, Horsman A (1997) Microvessel density of invasive breast cancer assessed by dynamic Gd-DTPA enhanced MRI. J Magn Reson Imaging 7: 461-464
7. Calvin DP, Hammond ME, Pajak TF, Trotti AM, Meredith RF, Rotman M, Jones CU, Byhardt RW, Demas WF, Ang KK, Fu KK (2007) Microvessel density > or =60 does not predict for outcome after radiation treatment for locally advanced head and neck squamous cell carcinoma: results of a correlative study from the Radiation Therapy Oncology Group (RTOG) 90-03 Trial. Am J Clin Oncol 30: 406-419
8. d'Arcy JA, Collins DJ, Padhani AR, Walker-Samuel S, Suckling J, Leach MO (2006) Informatics in radiology. Magnetic resonance imaging workbench: analysis and visualisation of dynamic contrast enhanced MR imaging data. Radiographics 26: 621-632
9. Des Guetz G, Uzzan B, Nicolas P, Cucherat M, Morere JF, Benamouzig R, Breau JL, Perret GY (2006) Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature. Br J Cancer 94: 1823-1832
10. Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG (2000) Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res 60: 1388-1393
11. Erdem O, Erdem M, Erdem A, Memis L, Akyol G (2007) Expression of vascular endothelial growth factor and assessment of microvascular density with CD 34 and endoglin in proliferative endometrium, endometrial hyperplasia, and endometrial carcinoma. Int J Gynecol Cancer 17: 1327-1332
12. Evelhoch JL (1999) Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging 10: 254-259
13. Evelhoch JL, LoRusso PM, He Z, DelProposto Z, Polin L, Corbett TH, Langmuir P, Wheeler C, Stone A, Leadbetter J, Ryan AJ, Blakey DC, Waterton JC (2004) Magnetic resonance imaging measurements of the response of murine and human tumors to the vascular-targeting agent ZD6126. Clin Cancer Res 10: 3650-3657
14. Fergenbaum J, Garcia-Closas M, Hewitt S, Lissowska J, Sakoda L, Sherman M (2004) Loss of antigenicity in stored sections of breast cancer tissue microarrays. Cancer Epidemiol Biomarkers Prev 13: 667-672
15. Fritz-Hansen T, Rostrup E, Larsson HB, Sondergaard L, Ring P, Henriksen O (1996) Measurement of the arterial concentration of Gd-DTPA using MRI: a step toward quantitative perfusion imaging. Magn Reson Med 36: 225-231
16. Gadducci A, Ferrero A, Cosio S, Zola P, Viacava P, Dompe D, Fanelli G, Ravarino N, Motta M, Cristofani R, Genazzani AR (2006) Intratumoral microvessel density in advanced epithelial ovarian cancer and its use as a prognostic variable. Anticancer Res 26: 3925-3932
17. Galbraith SM, Maxwell RJ, Lodge MA, Tozer GM, Wilson J, Taylor NJ, Stirling JJ, Sena L, Padhani AR, Rustin GJ (2003) Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging. J Clin Oncol 21: 2831-2842
18. Gulubova M, Vlaykova T (2007) Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer. J Gastroenterol Hepatol, doi:10.1111/j.1440-1746.2007.05009.X
19. Hawighorst H, Weikel W, Knapstein PG, Knopp MV, Zuna I, Schonberg SO, Vaupel P, van Kaick G (1998) Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. Clin Cancer Res 4: 2305-2312
20. Lind AJ, Wikstrom P, Granfors T, Egevad L, Stattin P, Bergh A (2005) Angiopoietin 2 expression is related to histological grade, vascular density, metastases, and outcome in prostate cancer. Prostate 62: 394-399
21. Kavantzas N, Paraskevakou H, Tseleni-Balafouta S, Aroni K, Athanassiades P, Agrogiannis G, Patsouris E (2007) Association between microvessel density and histologic grade in renal cell carcinomas. Pathol Oncol Res 13: 145-148
22. Metheny-Barlow LJ, Li LY (2003) The enigmatic role of angiopoietin-1 in tumor angiogenesis. Cell Res 13: 309-317
23. Moon WS, Park HS, Yu KH, Jang KY, Kang MJ, Park H, Tarnawski AS (2006) Expression of angiopoietin 1, 2 and their common receptor Tie2 in human gastric carcinoma: implication for angiogenesis. J Korean Med Sci 21: 272-278
24. Padhani AR, Hayes C, Landau S, Leach MO (2002) Reproducibility of quantitative dynamic MRI of normal human tissues. NMR Biomed 15: 143-154
25. Parker G, Suckling J, Tanner S, Padhani A, Revell P, Husband J, Leach M (1997) Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics. J Magn Reson Imaging 7: 564-574
26. Rustin GJ, Galbraith SM, Anderson H, Stratford M, Folkes LK, Sena L, Gumbrell L, Price PM (2003) Phase I clinical trial of weekly combretastatin A4 phosphate: clinical and pharmacokinetic results. J Clin Oncol 21: 2815-2822
27. Shim WS, Ho IA, Wong PE (2007) Angiopoietin: a TIE(d) balance in tumor angiogenesis. Mol Cancer Res 5: 655-665
28. Stomper PC, Winston JS, Herman S, Klippenstein DL, Arredondo MA, Blumenson LE (1997) Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions. Breast Cancer Res Treat 45: 39-46
29. Su MY, Cheung YC, Fruehauf JP, Yu H, Nalcioglu O, Mechetner E, Kyshtoobayeva A, Chen SC, Hsueh S, McLaren CE, Wan YL (2003) Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer. J Magn Reson Imaging 18: 467-477
30. Sullivan R, Graham CH (2007) Hypoxia-driven selection of the metastatic phenotype. Cancer Metastasis Rev 26: 319-331
31. Tanaka S, Sugimachi K, Yamashita Y, Shirabe K, Shimada M, Wands JR (2003) Angiogenic switch as a molecular target of malignant tumors. J Gastroenterol 38(Suppl 15): 93-97
32. Taylor N, Lankester K, Ah-See M-L, Stirling J, Rustin G, Makris A, D'Arcy J, Walker-Samuel S, Leach M, Padhani A (2004) Reproducibility of T1 and T2* weighted dynamic contrast-enhanced MRI: a multiparametric comparison of breast and abdominal tumours. Proc ISMRM, abstract 1975
33. Taylor NJ, d'Arcy JA, Walker-Samuel S, Lankester KJ, Collins DJ, Knowles B, White DL, Miaux Y, Suhy J, Guermazi A, Stirling JJ, Wallace T, Koh D-M, Tang A, Lee C, Rustin GJS, Leach MO, Padhani AR (2006) Single and multi-centre DCE-MRI reproducibility in Phase I clinical trials. In: Proc ISMRM pp. abstract 766: 14th annual meeting
34. Taylor NJ, Tunariu N, Ah-See M-L, Stirling JJ, Beresford MJ, Makris A, d'Arcy JA, Collins DJ, Padhani AR (2007) Effects of arterial input functions on dynamic MRI kinetic parameter estimates: an analysis of parameter variability and model fitting in breast cancer patients. In: Proc ISMRM pp. abstract 1975: 15th annual meeting
35. Tofts PS (1997) Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 7: 91-101
36. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, Port RE, Taylor J, Weisskoff RM (1999) Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10: 223-232
37. Tofts PS, Kermode AG (1991) Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 17: 357-367
38. Tozer GM, Kanthou C, Baguley BC (2005) Disrupting tumour blood vessels. Nat Rev Cancer 5: 423-435
39. Trivella M, Pezzella F, Pastorino U, Harris AL, Altman DG (2007) Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data. Lancet Oncol 8: 488-499
40. Tuncbilek N, Karakas HM, Altaner S (2004) Dynamic MRI in indirect estimation of microvessel density, histologic grade, and prognosis in colorectal adenocarcinomas. Abdom Imaging 29: 166-172
41. Wang HL, Deng CS, Lin J, Pan DY, Zou ZY, Zhou XY (2007) Expression of angiopoietin-2 is correlated with vascularization and tumor size in human colorectal adenocarcinoma. Tohoku J Exp Med 213: 33-40
42. Winter SF, Acevedo VD, Gangula RD, Freeman KW, Spencer DM, Greenberg NM (2007) Conditional activation of FGFR1 in the prostate epithelium induces angiogenesis with concomitant differential regulation of Ang-1 and Ang-2. Oncogene 26: 4897-4907
43. Zhao HC, Qin R, Chen XX, Sheng X, Wu JF, Wang DB, Chen GH (2006) Microvessel density is a prognostic marker of human gastric cancer. World J Gastroenterol 12: 7598-7603